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Nowadays, the high blood pressure is one of the main causes of death and cardiovascular diseases. 
Vasodilator drugs are frequently used to treat arterial hypertension. Experiments were undertaken to 
determine whether hydroalcoholic extracts obtained from leaves of field-grown Alpinia purpurata and A. 
zerumbet cultured in vitro under different plant growth regulators induce a vasodilator effect on Wistar 
rat mesenteric vascular bed pre-contracted with norepinephrine. Plant extracts were able to induce a 
long-lasting endothelium-dependent vasodilation. Efficiency on activity of A. purpurata reached 87% at 
concentration of 60 mg. The extract of A. zerumbet maintained in medium containing IAA, induced the 
relaxation (17.4%) at 90 μg, as compared to the control (MS0) that showed a better vasodilator effect 
(60%). These results are in agreement with the quantification of phenolic compounds in the extracts, 
which were 50% lower for those plants cultured in IAA. A. purpurata was assayed for the first time in 
relation to its vasodilator activity. This paper showed a strong probability of correlation between the 
pharmacological activities of A. purpurata with their content in phenolic compounds.
Uniterms: Alpinia purpurata (Vieill) K. Schum./pharmacognosy. A. zerumbet (Pers.) Burtt et Smith./
pharmacognosy. Natural vasodilators/experimental studies. Plant extracts/vasodilator action. Plant tissue/
culture. Endothelium-dependent. Flavonoids. Medicinal Plant. Plant growth/regulators. Zingiberaceae. 
Atualmente, a hipertensão arterial é uma das maiores causas de morte e de doenças cardiovasculares. Os 
vasodilatadores são freqüentemente utilizados no tratamento da hipertensão. Extratos hidroalcoólicos de 
Alpinia purpurata de campo e de A. zerumbet cultivada in vitro sob diferentes reguladores de crescimento 
vegetal foram ensaiados no leito mesentérico de ratos Wistar. Os extratos de A. purpurata e A. zerumbet 
produziram efeito vasodilatador com padrão de resposta dose-dependente de duração prolongada. Extratos 
da espécie A. purpurata tiveram efeito vasodilatador de 87% na dose de 60 μg. O extrato obtido de folhas 
de A. zerumbet oriundas das culturas mantidas em meio contendo AIA (ácido indol acético) inibiu o 
relaxamento (17,4%) na dose de 90 μg em relação ao controle (MS0), com o qual foi verificado melhor 
efeito vasodilatador (60%). Estes resultados estão de acordo com a concentração de fenóis totais que 
foi 50% menor para os extratos de plantas cultivadas in vitro em AIA. A espécie A. purpurata foi pela 
primeira vez ensaiada quanto à atividade vasodilatadora. Os resultados obtidos indicaram a presença de 
substâncias fenólicas provavelmente correlacionadas à ação terapêutica de A. purpurata.
Unitermos: Alpinia purpurata (Vieill) K. Schum./farmacognosia. Alpinia zerumbet (Pers.) Burtt et Smith./
farmacognosia. Vasodilatadores naturais/estudo experimental. Extratos vegetais/ação vasodilatadora. 
Tecidos vegetais/cultura. Endotélio-dependente. Flavonóides. Plantas medicinais. Crescimento vegetal/
reguladores. Zingiberaceae
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INTRODUCTION
Cardiovascular diseases are the main mortality cause 
in Brazil. Hypertension is characterized by blood pressure 
increase, related to heart effort to propel blood and the vas-
cular resistance (Godoy et al., 2007). This disease affects 
people from different ages and social ranges, and there 
are several attempts to minimize or prevent hypertension 
occurrence that, in their majority, involve adequate diet, 
physical exercises, and medications. In Brazil, several 
reports have evidenced the use of plants having antihy-
pertensive effects (Rocha et al., 2007). Alpinia zerumbet, 
known as ‘colônia’, is widely used in northeastern and 
southeastern Brazil as infusions or decoctions for treat-
ment of arterial hypertension. Hypotensive effects of this 
species have been justified by composition of hydroalco-
holic and aqueous extracts and essential oils (Soares de 
Moura et al., 1998; Victório et al., 2009a). According to 
Mendonça et al. (1991) a decrease blood pressure in rats 
and dogs was observed using hydroalcoholic extracts of 
A. zerumbet. Mpalantinos et al. (1998) suggested that fla-
vonoids and kavapyrones are responsible for vasodilator 
activity of aqueous extracts of A. zerumbet, while Lahlou 
et al. (2003) attributed it to some essential oil constituents 
therapeutic effects of A. zerumbet. A similarity between 
Alpinia purpurata and A. zerumbet was found in phyto-
chemical studies, in terms of essential oils and flavonoids 
composition (Victório, 2008; Victório et al., 2009b). The 
presence of flavonoids supported evidence for the chemo-
systematic features of the Zingiberiflorae, Zingiberaceae 
family (Pugialli et al., 1993; Victório et al., 2009b). Previ-
ous studies performed in animals have demonstrated that 
flavonoids are involved in vasodilator and hypotensive 
effects of A. zerumbet (Da Costa et al., 1998; Mpalantinos 
et al., 1998; Zheng-Tao et al., 2001; Lahlou et al., 2002; 
Lahlou et al., 2003; Soares de Moura et al., 2005). 
A. purpurata is a tropical plant that possesses high 
value in the international market for cut flowers due to 
the durability and exuberance of its inflorescences, on the 
other hand its phytochemical investigation is still scarce 
and studies about its therapeutic effects are incipient. Re-
cently, some flavonoids isolated from A. zerumbet have 
also been detected in A. purpurata extracts, what may 
corroborate the potential medicinal value of this species 
in treat arterial hypertension (Mpalantinos et al., 1998; 
Victório et al., 2007; Victório et al., 2009b). Flavonoids 
are known to possess cardioprotective properties and their 
isolation from different medicinal plants has exhibited 
antihypertensive action. Wang et al. (2004) suggested that 
flavonoids may act in vascular system as antiarrhythmic 
and vasodilator agents. Some commercialized medicines 
available to treat vascular diseases contain purified frac-
tions of flavonoids, as for example, DaflonÒ 500 mg. 
Flavonoids are antioxidants with health benefits acting 
in many hypotensive mechanisms such as inhibition of 
the angiotensin converting enzyme, blocking Ca+2 chan-
nels, inhibition of vasoconstrictor prostanoid synthesis 
and inducing relaxation elicited by bradikynin (Formica, 
Regelson, 1995; Pourcel et al., 2006; Havsteen, 2002; Xu 
et al., 2006).
Production of bioactive metabolites through plant 
tissue culture techniques has largely been adopted to op-
timize the content of terpenoids, flavonoids, alkaloids and 
many phenolic compounds by addition of plant growth 
regulators in culture media (Canter et al., 2005; Victório et 
al., 2008). Considering secondary metabolites production, 
this study also intended to evaluate vasodilator activity of 
plants obtained from tissue cultures of A. zerumbet main-
tained under growth regulators effects. 
Tests utilizing the rat mesenteric bed allow the va-
sodilator evaluation of plant extracts (McNeill, Jurgens, 
2006) and, depending on the results, could even suggest 
a hypotensive activity. The hypertension has as its main 
consequence, an inadequate tissue perfusion that increases 
the risks for cerebral vascular accidents and ischemic heart 
disease (Kaiser, 2004). The purpose of this work was to 
evaluate the vasodilator action of plants of A. purpurata, 
collected in Rio de Janeiro, and plants of A. zerumbet arose 
from in vitro cultures.
MATERIAL AND METHODS
Animals
All procedures concerning animals were carried out 
in an ethically proper way, by following guidelines as set 
by the World Health Organization. Experiments were also 
reviewed and approved by the Ethics Committee of Ani-
mal Experiments of the State University of Rio de Janeiro. 
Male two-month-old Wistar rats, weighing 230-260 g, 
were kept at constant room temperature (24-26 oC), under 
a 12-hour standard light/dark cycle, light period starting 
at 6 a.m., and free access to food and water. 
Plant material and preparation of extracts
Samples of A. zerumbet and A. purpurata leaves 
were collected from plants growing in Rio de Janeiro, at 
Universidade Federal do Rio de Janeiro (Rio de Janeiro 
state, Brazil). Voucher specimen was identified and is 
deposited at the Herbarium of Rio de Janeiro Botanical 
Garden, under accession number RB 433485 and RB 
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433484, respectively. Those A. zerumbet plants were 
used as explants donor for tissue cultures establishment 
according to Victório, 2008. A. zerumbet was cultured in 
glass bottles containing 60 mL of MS (Murashige, Skoog, 
1962) medium, added 30 g.L-1 of sucrose, vitamins and 
myo-inositol. The following growth regulator treatments 
were evaluated for 60 days: MS0 (control); MS + 2 mg.L-1 
indole-3-acetic acid (IAA 2) and; MS + 2 mg.L-1 IAA + 
2 mg.L-1 thidiazuron (TDZ 2). Cultures were maintained 
under white light (fluorescent tubs, 20 W, T–12, General 
Electric®), intensity of 30 µmol.m-2.s-1, daily photoperiod 
of 16 hours, at 25 ± 2 °C. The design of the experiments 
was a complete randomized block, and each experiment 
consisted of three explants per glass and the minimum 
of ten replicate culture flasks per plant growth regulator 
treatments.
Leaves from field-grown donor plants were dried for 
3 days in stove (60 oC) and macerated in 50% ethanol (1:20 
w/v) using ultrasonic bath (40 kHz, Thornton Unique, mo-
del 1400 USC) for 45 min, at 60 ºC. Leaves obtained of in 
vitro cultures were dried by lyophilization and extracted in 
50% ethanol as described above. All determinations were 
carried out in triplicates. The crude extracts were filtered 
in vacuum using a Whattman® filter (110 mm Ø, 1) and 
dried by rotary evaporation. 
Total phenolics
Total phenolics compounds were determined using 
the Folin-Ciocalteau method (Singleton, Rossi, 1965). 
Hydroalcoholic extracts were dissolved in ethanol (70%) 
at 1mg/mL. An aliquot of 0.5 mL of diluted extract and 2 
mL Folin-Ciocalteau reagent (10%) were added, after 3 
min, along with 2 mL of 7.5% sodium carbonate, and the 
contents were mixed. The mixture was homogenized and 
incubated at 50 oC for 30 min. The absorbance was mea-
sured at 740 nm in a spectrophotometer using gallic acid 
as standard. Two controls were used: (1) Folin-Ciocalteau 
+ sodium carbonate and (2) crude extract solution. The 
quantification of phenolic compounds in crude extracts 
was determined from regression equation of calibration 
curves: y = 0.0229x + 0.0968 (R2 = 0.9993) and expres-
sed as mg gallic acid equivalents (GAE) per 1 g of dried 
leaves. All determinations were carried out in triplicates. 
High performance liquid chromatography analysis
Crude extracts were filtered in vacuum, dissolved in 
methanol: Milli-Q water (50%) at 10 mg/mL (field-grown) 
and 50 mg/mL (in vitro cultures). HPLC-UV analyses were 
performed on an apparatus Shimadzu equipped with SPD-
M10A diode array detector, LC-10AD pump and CBM-10 
interface. Data were acquired and processed by a reversed 
phase column (Lichrosorb® RP-18 25 cm x 4.6 nm, 5 µm), 
room temperature. Separation was done in the following 
mobile phase: MilliQ water + 0.1% phosphoric acid (A) 
and methanol (B): 1-10 min (30% B); 20 min (40% B); 60 
min (100% B) (Victório et al., 2009b). The flow rate was 
kept constant at 1 mL/min and the peaks were detected at 
360 nm. All chemical used in analysis as methanol and 
phosphoric acid were of HPLC grades and were purchased 
from Merck. MilliQ water was utilized to HPLC mobile 
phase and sample preparation. Standards were dissolved in 
methanol 70% at 1 mg/mL and analyzed in the same elu-
tion. The injections of 20 mL were repeated in triplicates. 
Determination of the content of the flavonoids was per-
formed by the external standard method, using authentic 
standards of rutin and kaempferol-3-O-β-D-glucuronide. 
Quantification of flavonoids in the extracts was obtained 
against calibration curves of standards.
Isolated mesenteric vascular bed
Experiments were undertaken to determine whether 
hydroalcoholic extracts obtained from leaves of field-
grown Alpinia purpurata and A. zerumbet cultured in 
vitro under different plant growth regulators induce a 
vasodilator effect in the Wistar rat mesenteric vascular 
bed pre-contracted with norepinephrine. Crude extracts 
were dissolved in ethanol: Milli-Q water (1:1) at 1 mg/
mL concentration.
The rat superior MVB (Mesenteric Vascular Bed) 
was isolated according to McGregor (1965). Male Wistar 
rats were killed with inhaled CO
2
 and superior MVB was 
cannulated with a 4 cm polyethylene tube (PE 50, Clay 
Adams Brand CA – Becton Dickinson) and perfused at a 
flow rate 4 mL/min with a physiological salt solution (PSS) 
by pulsatile pump (Life Care Pump, Model 4 – Abbott / 
Shaw). The PSS had the following composition (mM): 
NaCl 118.3; KCl 4.7; CaCl2.2H2O 2.5; MgSO4.6H2O 1.2; 
KH2PO4 1.2; NaHCO3 25.0; EDTA 0.026 and glucose 11.1. 
The PSS (37oC) was bubbled with O2 95% and CO2 5%. 
Perfusion pressure (PP) was measured with a transducer 
connected to a preamplifier (Hewlett Packard - 7754 A) 
and chart recorded. Drugs were either dissolved in PSS and 
perfused at the desired concentration or administered as 
bolus injections directly into the perfusion stream (volume 
<300 mL).
The preparations were left to equilibrate for 40 min, 
and then injections of 120 μmol of KCl were administered 
every 10 min until consistent responses were obtained. 
The basal perfusion pressure after the equilibration period 
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oscillated between 20 and 25 mmHg. The hydroalcoholic 
extracts were injected in bolus after the PP had been el-
evated (80-110 mmHg) with norepinephrine (NE, 30 μM) 
added to the perfusion fluid. When the pressor effect of 
NE reached a plateau, acetylcholine (Ach, 10 pmol) and 
nitroglycerin (NG, 10 nmol) were injected to test the 
endothelium-dependent and endothelium-independent va-
sodilator responses before dose-response curves to crude 
extracts were obtained. The vasodilator effect of drugs was 
expressed as a percentage decrease in relation to the pres-
sor effect of NE. Crude extracts were administered in bolus 
in increasing doses 1, 3, 6, 10, 30, 60 and 90 μg (n=6).
Statistical Analysis
The vasodilator effect of drugs was expressed as the 
percentage decrease in the increase in PP induced by NE. 
PP variations among experimental groups are presented as 
average ± standard error for the number of rats and were 
compared using Bonferroni unpaired test. A value of P less 
than 0.05 was used to indicate significance.
RESULTS AND DISCUSSION
Chromatographic profiles of A. zerumbet and A. 
purpurata hydroalcoholic extracts indicated flavonoids 
which were suggested as contributing for antihyperten-
sive vasodilator effects of A. zerumbet (Mpalantinos et 
al., 1998; Victório et al., 2009b). The content of rutin 
and kaempferol-3-O-β-D-glucuronide in dried extracts 
of A. zerumbet and A. purpurata leaves is shown in Table 
I. Higher kaempferol-3-O-β-D-glucuronide content was 
found in leaves of A. zerumbet (4.74 mg.100 mg-1 dried ex-
tract) compared to A. purpurata extracts (0.20 mg.100 mg-1 
dried extract). The increasing in total phenolics was ob-
served in A. zerumbet cultured in control medium (66.8 μg 
GAE.mg-1), while plantlets maintained under IAA 2 treat-
ment produced lower than 50% of phenolics (26.2 μg 
GAE.mg-1) (Table I). These data are in accordance with 
the high or low effect of A. zerumbet extracts from tissue 
cultures on MVB. The production of phenolic compounds 
through tissue cultures has been verified in studies with 
different medicinal plants (Konczak-Islam et al., 2003; 
Victório et al., 2008). Phenolic compounds are antioxi-
dants responsible for free radical scavenging, capable of 
minimizing the damaging effects of reactive oxygen spe-
cies, and considered potential compounds to preventing 
cardiovascular diseases (Khan, Mukhtar, 2007).
Vasodilator effect of Alpinia purpurata extracts
Isolate rat MVB was perfused with PSS solution, at 
4 mL/min, and presented basal average perfusion pressure 
around 25 to 30 mmHg. Functionally, the in bolus injec-
tion of 120 μmol of KCl increased the perfusion pressure 
up to 80 mmHg and demonstrated the viability of MVB 
preparation. Addition of 30 μM of NE in the perfusion 
solution induced firstly an increase of perfusion pressu-
re, and then maintained it constant, in the level of 84 to 
120 mmHg; which has enabled the study of vasodilator 
effect of hydroalcoholic extract of A. purpurata. The in bo-
lus administration of 10 pmol of ACh and 10 nmol of NG 
decreased the perfusion pressure, confirming the integrity 
of endothelium and vascular smooth muscle, respectively. 
The administration of increasing doses of A. purpurata 
extract (3, 6, 10, 30, and 60 μg) produced a dose-dependent 
vasodilator effect of long-lasting duration, similar to 
patterns of response of A. zerumbet extracts (Soares de 
Moura et al., 2005) (Figure 1). The response risen as the 
dose increased from 6 μg upward (Figure 2). Vasodilator 







(mg.100 mg-1 dried extract)
A. zerumbet
Field 58.1±3.6 31.23 0.48 -
34.77 - 4.74
In vitro
MS0 66.8±3.4 0.0003 0.028
IAA 2 26.2±2.0 0.024 0.018
IAA 2 + TDZ 2 43.7±1.4 0.134 0.032
A. purpurata
Field 30.1±1.8 32.31 0.58
35.52 0.20
RT – retention time. *Average ± SE.
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effect of hydroalcoholic extract of A. zerumbet was more 
effective, than that of A. purpurata extract verified in the 
present study; being reversed more than 50% of constric-
tive effect of NE, in the dose of 6 μg (Emiliano, 2002). 
However, A. purpurata extracts have shown a rising and 
continuous relaxation (Figure 2), with the same intensity 
of results obtained for A. zerumbet in the dose of 60 μg 
(Emiliano, 2002). The effects of A. purpurata extracts 
on MVB reached 87% potency at 60 mg (Figure 2). The 
similarities respecting to response and vasodilator effect 
of these species could be related to presence of common 
secondary metabolites. The A. purpurata species, as well 
as the A. zerumbet, are natural sources of flavonoids, such 
as rutin, derived from quercetin, and the kaempferol-3-O-
β-D-glucuronide. Both are referred for their typical vaso-
dilator and anti-hypertensive actions (Formica, Regelson, 
1995; Perez-Vizcaino et al., 2002; Xu et al., 2006). Recent 
researches conducted by Ferreira et al. (2007), showed that 
rutin is one of the main flavonoids in ethanolic extracts of 
Hancornia speciosa and that this extract has contributed 
for endothelium-dependent vasodilator activity in the 
mesenteric artery of rats. The endothelium-independent 
vasodilator action was also verified in studies with the 
flavonoid quercetin (Perez-Vizcaino et al., 2002).
In studies developed by Emiliano (2002), it was 
suggested that the vasodilator effect of hydroalcoho-
lic extract of A. zerumbet is endothelium-dependent, 
being it related to NO (nitrogen oxide) production, a 
vasodilator agent that acts increasing the activity of the 
enzyme soluble guanylate cyclase, which by its time, 
induces the production of cyclic guanosine monophos-
phate – the cGMP (Nagao, Vanhoutte, 1991). According 
to these results, the popular use of A. zerumbet in cases 
of arterial hypertension show positive responses, due to 
action of the extract for decreasing the peripheral resis-
tance (Emiliano, 2002). Such suggestion could be also 
conferred for the extract of A. purpurata, however, the 
results obtained are preliminary and other plant material 
collected from different geographic regions, and biolo-
gical assays to confirm the species vasodilator effect, 
would be necessary. Mpalantinos (2001), in studies with 
aqueous extracts of A. zerumbet from different Brazilian 
regions, has obtained different results in relation to va-
sodilator activity. Inclusively, for some of these extracts 
of A. zerumbet, the vasodilator activity was lower than 
that for A. purpurata in current study (Figure 2). The 
environmental conditions exert some influence over the 
production of secondary metabolites, and this fact, in its 
turn, alters the dose-effect curves.
Vasodilator effect of Alpinia zerumbet cultured 
in vitro
A. zerumbet extracts obtained from in vitro cultures 
have shown different responses on MVB, but always 
with dose-dependent vasodilator standard of long-lasting 
duration (Figure 3). The extracts of A. zerumbet cultured 
in media containing plant growth regulators decreased the 
vasodilator effects compared to plantlets cultured in MS0, 
except for treatment IAA 2 + TDZ 2 in the doses of 30 and 
60 μg. These findings may indicate the inhibitory effect of 
IAA 2 mg.L-1 on the production of secondary metabolites, 
as the isolated administration of IAA 2 resulted in inhi-
bition higher than that of the combination IAA 2 + TDZ 
2. Extracts from plantlets maintained in control medium 
were more effective when inducing the vasodilator res-
ponse with respect to other in vitro treatments, probably, 
FIGURE 1 - Representative perfusion pressure (mmHg) 
trace showing the vasodilator effect of Alpinia purpurata 
hydroalcoholic extracts on MVB pre-contracted with NE 
(30 mM) added to the perfusion fluid. Acetylcoline (Ach, 10 
pmol) and Nitroglycerin (NG, 10 nmol) were also injected to test 
the endothelium-dependent and independent responses before 
dose-responses curves to extracts were obtained.
FIGURE 2 -  Vasodilator effect of Alpinia purpurata 
hydroalcoholic extracts on MVB pre-contracted with NE. Each 
point represents the average ± SE, n ≥ 6.
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due to higher concentration of phenolic compounds. The 
maximum response obtained for the extracts of plantlets 
from in vitro cultures was of 60% de relaxation in the dose 
of 90 μg, against 95% of field plants at 60 μg. Although 
tissues culture techniques constitute an important tool for 
the large scale production of plant raw material and in the 
optimized production of bioactive compounds as well, the 
results obtained for the in vitro production of secondary 
metabolites were not improved, even under the effect of 
growth regulators. However, important results could be 
suggested, with the inhibition of secondary metabolic pa-
thways by the auxin IAA, in accordance with the decrease 
of total phenolics in extracts arising from this treatment. 
CONCLUSION
Although the hydroalcoholic extracts of A. purpura-
ta have shown vasodilator action, the required efficiency 
and potency combination to enable the production of a 
drug was not obtained. The studies are preliminary. Ho-
wever, phenolic compounds and flavonoids were detected 
for A. purpurata species, which has not excluded it as a 
possible natural source for obtaining bioactive compounds 
useful against hypertension.
No treatment with plant growth regulators has 
induced higher production of flavonoids in A. zerumbet 
plantlets, which probably are the responsible agents for the 
vasodilator effect. But the higher concentration of phenolic 
compounds verified in leaves of plantlets cultured in MS0 
medium has resulted in a better vasodilator effect.
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